Biocryst Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Biocryst Pharmaceuticals Inc
TickerBCRX
CIK #0000882796
CUSIP09058V103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address2190 Parkway Lake Dr, Birmingham, AL 35244
Source [EDGAR]
CIK Filing 2011 - 2025
[0000882796] 10-K
[0000882796] 10-Q
[0000882796] 3
[0000882796] 4
[0000882796] 8-K
[0000882796] SC 13D
[0000882796] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Avoro Capital Advisors LLC Biocryst Pharmaceuticals Inc [2024-02-14] 6.4
State Street Corp Biocryst Pharmaceuticals Inc [2021-02-05] 6.26
Sarissa Capital Management LP Biocryst Pharmaceuticals Inc [2021-01-25] 5.0
Citadel Advisors LLC Biocryst Pharmaceuticals Inc [2020-06-10] 4.8
Adage Capital Partners GP LLC Biocryst Pharmaceuticals Inc [2020-04-17] 1.62
Point72 Asset Management LP Biocryst Pharmaceuticals Inc [2019-11-19] 6.0
Integrated Core Strategies US LLC Biocryst Pharmaceuticals Inc [2019-05-29] 5.6
Venrock Healthcare Capital Partners II LP Biocryst Pharmaceuticals Inc [2019-02-14] 5.8
Great Point Partners LLC Biocryst Pharmaceuticals Inc [2019-01-11] 6.95
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2018-04-02] 7.1
Great Point Partners LLC Biocryst Pharmaceuticals Inc [2018-02-16] 7.6
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2018-02-14] 7.1
Janus Henderson Group PLC Biocryst Pharmaceuticals Inc [2018-02-12] 6.8
Vanguard Group Inc Biocryst Pharmaceuticals Inc [2018-02-08] 5.87
Flynn James E Biocryst Pharmaceuticals Inc [2017-06-05] 6.81
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2017-03-06] 5.0
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2017-01-09] 5.0
RTW Investments LLC Biocryst Pharmaceuticals Inc [2016-08-26] 5.02
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2016-08-22] 5.1
Baker Bros Advisors LP Biocryst Pharmaceuticals Inc [2016-08-17] 14.95
Flynn James E Biocryst Pharmaceuticals Inc [2016-08-12] 6.64
Venrock Healthcare Capital Partners LP Biocryst Pharmaceuticals Inc [2016-03-28] 7.1
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2016-03-14] 5.1
Baker Bros Advisors LP Biocryst Pharmaceuticals Inc [2015-11-06] 19.5
BlackRock Inc Biocryst Pharmaceuticals Inc [2015-02-02] 7.6
Baker Julian Biocryst Pharmaceuticals Inc [2014-02-25] 11.3
Wellington Management Co LLP Biocryst Pharmaceuticals Inc [2014-02-14] 8.11
FMR LLC Biocryst Pharmaceuticals Inc [2014-02-10] 0.0
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2013-08-09] 0.9
RTW Investments LLC Biocryst Pharmaceuticals Inc [2013-08-02] 5.1
BlackRock Inc Biocryst Pharmaceuticals Inc [2013-01-30] 6.16
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2012-03-16] 6.5
Form 3/4/5 Filer 2011 - 2025
Heggie Theresa
Biocryst Pharmaceuticals Inc
Ghias Babar
McKee Amy E
Galson Steven K
Frank Steven
Sanders Machelle
Milano Vincent
Levin Alan G
Hutson Nancy J
Thackray Helen M.
Stonehouse Jon P
Barnes Alane P
Doyle Anthony
Gayer Charles K
Abercrombie George B
Aselage Steve
Lee Kenneth B Jr
Ingram Robert Alexander
Jones Michael L
Babu Yarlagadda S
Sheridan William P
Sniecinski Megan
Staab Thomas R II
Powell Lynne
Erck Stanley C
Cohen Fred E
Patel Sanj K
Baker Bros Advisors LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Baker Julian
Sanders Charles A
Jensen Peder
Baker Bros. Investments II, L.P.
Baker/Tisch Investments, LP
667 LP
Baker Bros. Investments, L.P.
Baker Brothers Life Sciences LP
14159 LP
Higgins John L
Horovitz ZOLA P
Lowrey Robert S
McCullough David
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 20,482,553 21,425,849
Vanguard Group Inc [2025-06-30] SOLE 0 20,040,273
State Street Corp [2025-06-30] DFND 7,931,722 8,505,392
Kynam Capital Management LP [2025-06-30] SOLE 8,463,742 8,463,742
UBS Group AG [2025-06-30] DFND 5,617,177 5,622,651
Morgan Stanley [2025-06-30] DFND 5,145,016 5,329,679
Geode Capital Management LLC [2025-06-30] DFND 5,054,610 5,054,610
Alkeon Capital Management LLC [2025-06-30] SOLE 4,762,021 4,762,021
Deerfield Management Company LP [2025-06-30] DFND 4,692,000 4,692,000
Avoro Capital Advisors LLC [2025-06-30] SOLE 4,500,000 4,500,000
D. E. Shaw & Co., Inc. [2025-06-30] DFND 4,321,377 4,389,477
Two Sigma Investments LP [2025-06-30] SOLE 4,288,223 4,288,223
Arrowstreet Capital Limited Partnership [2025-06-30] DFND 4,278,555 4,278,555
Two Sigma Advisers LP [2025-06-30] SOLE 4,079,912 4,228,412
Assenagon Asset Management S.A. [2025-06-30] SOLE 3,620,637 3,620,637
Nuveen, LLC [2025-06-30] DFND 3,460,473 3,534,454
Goldman Sachs Group Inc [2025-06-30] DFND 3,518,614 3,523,917
Bank of America Corp /DE/ [2025-06-30] DFND 140,698 2,841,155
Fisher Asset Management LLC [2025-06-30] DFND 1,492,319 2,782,489
Citadel Advisors LLC [2025-06-30] DFND 2,718,632 2,718,632
Renaissance Technologies LLC [2025-06-30] SOLE 2,526,734 2,526,734
Voloridge Investment Management LLC [2025-06-30] SOLE 2,474,075 2,474,075
Qube Research & Technologies Ltd [2025-06-30] SOLE 2,373,489 2,373,489
Walleye Capital LLC [2025-06-30] SOLE 2,311,928 2,311,928
Rice Hall James & Associates LLC [2025-06-30] SOLE 1,640,999 2,060,280
Millennium Management LLC [2025-06-30] SOLE 1,906,667 2,006,667
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,969,875 1,969,875
Northern Trust Corp [2025-06-30] DFND 1,880,276 1,881,333
Jupiter Asset Management Ltd [2025-06-30] SOLE 1,855,863 1,855,863
Stifel Financial Corp [2025-06-30] DFND 1,822,976 1,823,288
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com